Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Insmed informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
oct 30
Estimación de BPA
$-1.370
Estimación de ingresos trimestrales
$114.40M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$398.11M
Analice el historial de beneficios de Insmed utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
INSM | Insmed | -$1.27 | -$1.37 | — | — | $93.42M | $114.40M | — | — | 10/30/2025 | |
INSM | Insmed | -$1.94 | -$1.31 | -$1.70 | -29.77% | $90.34M | $103.96M | $107.42M | 3.33% | 08/07/2025 | |
INSM | Insmed | -$1.06 | -$1.36 | -$1.42 | -4.41% | $75.50M | $92.09M | $92.82M | 0.80% | 05/08/2025 | |
INSM | Insmed | -$1.28 | -$1.16 | -$1.32 | -13.79% | $83.69M | $102.31M | $104.44M | 2.08% | 02/20/2025 | |
INSM | Insmed | -$1.11 | -$1.22 | -$1.27 | -4.10% | $79.07M | $93.01M | $93.42M | 0.45% | 10/31/2024 | |
INSM | Insmed | -$1.78 | -$1.27 | -$1.94 | -52.76% | $77.23M | $87.95M | $90.34M | 2.72% | 08/08/2024 | |
INSM | Insmed | -$1.17 | -$1.23 | -$1.06 | 13.82% | $65.21M | $78.58M | $75.50M | -3.92% | 05/09/2024 | |
INSM | Insmed | -$1.21 | -$1.15 | -$1.28 | -11.30% | $59.30M | $82.76M | $83.69M | 1.13% | 02/22/2024 | |
INSM | Insmed | -$1.09 | -$1.12 | -$1.11 | 0.89% | $67.73M | $79.13M | $79.07M | -0.07% | 10/26/2023 | |
INSM | Insmed | -$0.80 | -$1.10 | -$1.78 | — | $65.22M | $70.25M | $77.23M | 9.93% | 08/03/2023 | |
INSM | Insmed | -$0.80 | -$1.11 | -$1.17 | -5.41% | $53.11M | $64.51M | $65.21M | 1.09% | 05/04/2023 | |
INSM | Insmed | -$0.95 | -$1.04 | -$1.21 | -16.35% | $56.12M | $62.28M | $59.30M | -4.78% | 02/23/2023 | |
INSM | Insmed | -$0.96 | -$0.89 | -$1.09 | -22.47% | $46.76M | $66.46M | $67.73M | 1.91% | 10/27/2022 | |
INSM | Insmed | -$0.91 | -$0.89 | -$0.80 | 10.11% | $45.37M | $59.41M | $65.22M | 9.78% | 08/04/2022 | |
INSM | Insmed | -$0.89 | -$0.88 | -$0.80 | 9.09% | $40.21M | $53.36M | $53.11M | -0.47% | 05/05/2022 | |
INSM | Insmed | -$1.00 | -$0.90 | -$0.95 | -5.56% | $41.41M | $50.78M | $56.12M | 10.52% | 02/17/2022 | |
INSM | Insmed | -$0.63 | -$0.86 | -$0.96 | -11.63% | $43.64M | $49.23M | $46.76M | -5.02% | 10/28/2021 | |
INSM | Insmed | -$0.64 | -$0.85 | -$0.91 | -7.06% | $42.49M | $43.72M | $45.37M | 3.76% | 08/05/2021 | |
INSM | Insmed | -$0.74 | -$0.88 | -$0.89 | -1.14% | $36.86M | $41.64M | $40.21M | -3.42% | 05/06/2021 | |
INSM | Insmed | -$0.59 | -$0.70 | -$1.00 | -42.86% | $45.71M | $41.44M | $41.41M | -0.06% | 02/25/2021 | |
INSM | Insmed | -$0.68 | -$0.61 | -$0.63 | -3.28% | $38.88M | $46.07M | $43.64M | -5.27% | 10/29/2020 |
Insmed (INSM) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $-1.70 | $-1.31 | -29.8 % |
| Q1 | 2025-05-08 | $-1.42 | $-1.36 | -4.41 % |
| Q4 | 2025-02-20 | $-1.32 | $-1.16 | -13.8 % |
| Q3 | 2024-10-31 | $-1.27 | $-1.22 | -4.10 % |
Insmed (INSM) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $107.42M | $103.96M | 3.33 % |
| Q1 | 2025-05-08 | $92.82M | $92.09M | 0.80 % |
| Q4 | 2025-02-20 | $104.44M | $102.31M | 2.08 % |
| Q3 | 2024-10-31 | $93.43M | $93.01M | 0.45 % |
PREGUNTAS FRECUENTES
¿Cuándo Insmed (NASDAQ:INSM) publicará los resultados?
Está previsto que Insmed (INSM) presente resultados el octubre 30, 2025. Los últimos resultados se publicaron el agosto 7, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Insmed (NASDAQ:INSM)?
El BPA real fue de $-1.70, que no alcanzó la estimación de $-1.31.
¿Cuáles fueron los ingresos de Insmed (NASDAQ:INSM)?
Los ingresos reales fueron $107.4M, que superó la estimación de $104M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.